Use a sterile syringe
Participants in the trial taking tirzepatide instead of the placebo achieved average weight reductions of 16% (or 35 pounds) with a 5-milligram dose, 21.4% (or 49 pounds) on a 10-milligram dose, and 22.5% (or 52 pounds) on a 15-milligram dose
AOD 9604 users who report positive results typically notice changes after 4 to 8 weeks of daily use, primarily in stubborn fat areas
The difference in these structures is shown in the figures below
Gudbergsen H, Henriksen M, Waehrens EE, Overgaard A, Bliddal H, Christensen R, Boesen MP, Knop FKK, Astrup A, Rasmussen MU, Bartholdy C, Daugaard C, Bartels EM, Ellegaard K, Heitmann BL, Kristensen LE (2019) Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial
however, metabolic acidosis in pregnancy (due to other causes) can cause decreased fetal growth, decreased fetal oxygenation, and fetal death, and may affect the fetus ability to tolerate labor